In another study, Bagalagel et al. [24] evaluated the potential therapeutic effects of cycloastragenol in experimentally induced ulcerative colitis rats and examined the modulation of sphingosine kinase (SphK), macrophage inflammatory protein (MIP)-1α, and miR-143. The gene discussed is SPHK1; the disease is ulcerative colitis.